Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-069314
Filing Date
2024-06-05
Accepted
2024-06-05 16:10:58
Documents
1
Period of Report
2024-05-30

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 4203
  Complete submission text file 0000950170-24-069314.txt   5786
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address
Jackson Scott Thomas (Reporting) CIK: 0001566617 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41837 | Film No.: 241022113

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Issuer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)